CMS(00867),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00867 CMS

Closed 11-11 16:08:05

10.390

-0.150

-1.42%

High10.490	Low10.210	Vol1.40M
Open10.430	D1 Closing10.540	Amplitude2.66%
Mkt Cap25.28B	Tradable Cap25.28B	Total Shares2.43B
T/O14.47M	T/O Rate0.06%	Tradable Shares2.43B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00867","market":"HK","secType":"STK","nameCN":"CMS","latestPrice":10.39,"timestamp":1794384485003,"preClose":10.54,"halted":0,"volume":1400000,"delay":0,"changeRate":-0.014231499051233262,"floatShares":2433000000,"shares":2433000000,"eps":0.6154,"marketStatus":"Closed","change":-0.15,"latestTime":"11-11 16:08:05","open":10.43,"high":10.49,"low":10.21,"amount":14469330,"amplitude":0.026565,"askPrice":10.39,"askSize":24000,"bidPrice":10.38,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":0.731688,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1794447000000},"marketStatusCode":5,"adr":0,"listingDate":1285603200000,"exchange":"SEHK","adjPreClose":10.54,"dividendRate":0.033942,"openAndCloseTimeList":[[1794360600000,1794369600000],[1794373200000,1794384000000]],"volumeRatio":0.362609,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00867/tweets","defaultTab":"tweets","newsList":[{"id":"2681076733","title":"Sight Sciences Announces CMS Establishment of a Practice Expense Supply Code for TearCare SmartLids","url":"https://stock-news.laohu8.com/highlight/detail?id=2681076733","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681076733?lang=en_us&edition=fundamental","pubTime":"2026-11-05 21:00","pubTimestamp":1793883600,"startTime":"0","endTime":"0","summary":"New direct practice expense supply code supports more consistent valuation of CPT 0563TMENLO PARK, Calif., Nov.  05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or th","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/11/05/3396356/0/en/sight-sciences-announces-cms-establishment-of-a-practice-expense-supply-code-for-tearcare-smartlids.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004220.SGD","IE00BVYPNQ40.USD","SG9999015978.USD","LU1894683264.USD","SG9999015945.SGD","PFS","BK1191","BK4195","SG9999004311.SGD","LU2637428348.USD","IE00BMCWC346.EUR","SG9999015986.USD","BK4082","BK4211","LU0545039389.USD","LU2488822045.USD","CMS","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","LU0553294199.USD","BK4585","LU0738911758.USD","LU1894683348.USD","LU2500361329.USD","BK4208","SG9999015952.SGD","BK4588","SGHT","BK4539","BK1593","LU0661504455.SGD","00867","LU1003077747.HKD","IE00BYV24P56.USD","LU2346227817.USD","LU0949170772.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681783140","title":"Lantheus Welcomes CMS CY27 Final Rule Advancing Access to Diagnostic Radiopharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2681783140","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681783140?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:15","pubTimestamp":1793880900,"startTime":"0","endTime":"0","summary":"Final rule maintains separate payment for advanced diagnostic imaging agents and confirms PYLARIFY TruVu Transitional Pass-Through status through September 30, 2029; permanent HCPCS code A9613 now in ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/11/05/3396291/0/en/lantheus-welcomes-cms-cy27-final-rule-advancing-access-to-diagnostic-radiopharmaceuticals.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","ADT.AU","BK4084","SG9999004220.SGD","BK7095","SG9999015952.SGD","IE00BVYPNP33.GBP","SG9999015986.USD","LU0949170772.SGD","REZ","BK4192","BK7047","BK4208","IE00BGHQDM52.EUR","LU2488822045.USD","BK4165","LNTH","LU2500361329.USD","PSA","PSA.AU","HAUS","LU0545039389.USD","LU0661504455.SGD","LU2637428348.USD","IE00BVYPNQ40.USD","LU1003077747.HKD","LU1894683348.USD","BK7142","IE00BYV24P56.USD","BK4585","SG9999015945.SGD","BK4588","BK4533","00867","IE00BMCWC346.EUR","ADT","SG9999015978.USD","BK4217","BK1191","CMS","REAI","BK1593","LU0738911758.USD","INDS","LU1894683264.USD","PET.AU","SG9999004311.SGD","LU2346227817.USD","LU0553294199.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103656415","title":"Hong Kong Stock Movers: CMS Surges Over 4% as Innovative Drug Ruxolitinib Phosphate Cream Wins Singapore Marketing Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1103656415","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103656415?lang=en_us&edition=fundamental","pubTime":"2026-11-05 11:08","pubTimestamp":1793848097,"startTime":"0","endTime":"0","summary":"Shares of CMS (00867) rose more than 4%, reaching 4.24% higher at HK$10.57 as of press time, with turnover of HK$10.9292 million.On the news front, on November 4, CMS announced that its subsidiary...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYV24P56.USD","BK4588","VXUS","IBBQ","SG9999004220.SGD","00867","06978","SG9999015986.USD","IE00BVYPNQ40.USD","BK1593","BK1574","SG9999015945.SGD","IE00BMCWC346.EUR","SG9999015952.SGD","SG9999004311.SGD","BK1161","SG9999015978.USD","BK1191","MEDX","LNGR","STmain","IE00BGHQDM52.EUR","LU2488822045.USD","BK4585","IPOS","KCAI","159992","IE00BVYPNP33.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128615092","title":"CMS Pharma's Innovative Drug Ruxolitinib Phosphate Cream Wins Singapore Marketing Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1128615092","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128615092?lang=en_us&edition=fundamental","pubTime":"2026-11-04 06:40","pubTimestamp":1793745622,"startTime":"0","endTime":"0","summary":"CMS (00867) has announced that its subsidiary Rxilient Medical received approval from the Health Sciences Authority of Singapore (HSA) on November 3, 2026, for the New Drug Application (NDA) of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LNGR","SG9999015986.USD","IE00BVYPNP33.GBP","STmain","00867","SG9999015978.USD","MEDX","BK1191","IE00BMCWC346.EUR","BK1574","BK1593","IE00BYV24P56.USD","SG9999015945.SGD","IBBQ","SG9999015952.SGD","159992","LU2488822045.USD","IPOS","IE00BGHQDM52.EUR","BK1161","SG9999004311.SGD","SG9999004220.SGD","IE00BVYPNQ40.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680870569","title":"China Medical System Unit Rxilient Medical Wins Singapore Approval for Vitiligo Cream","url":"https://stock-news.laohu8.com/highlight/detail?id=2680870569","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680870569?lang=en_us&edition=fundamental","pubTime":"2026-11-04 06:34","pubTimestamp":1793745273,"startTime":"0","endTime":"0","summary":"China Medical System Unit Rxilient Medical Wins Singapore Approval for Vitiligo CreamChina Medical System subsidiary Rxilient Medical secured Singapore approval for ruxolitinib phosphate cream, brande","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nNDL7sl3fT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004311.SGD","BK1593","SG9999015952.SGD","BK1191","IE00BYV24P56.USD","IE00BVYPNQ40.USD","IE00BMCWC346.EUR","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","SG9999015986.USD","LU2488822045.USD","SG9999015978.USD","SG9999015945.SGD","00867","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680703111","title":"China Medical System Holdings - Rxilient Medical Receives Hsa Approval for Nda of Ruxolitinib Phosphate Cream on Nov 3, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2680703111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680703111?lang=en_us&edition=fundamental","pubTime":"2026-11-04 06:10","pubTimestamp":1793743827,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nFWN46K29O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","IE00BYV24P56.USD","00867","BK1593","SG9999015978.USD","IE00BMCWC346.EUR","SG9999015952.SGD","SG9999015945.SGD","SG9999015986.USD","IE00BVYPNQ40.USD","SG9999004220.SGD","SG9999004311.SGD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679220165","title":"Elite Founder Led Stocks To Own In October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2679220165","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679220165?lang=en_us&edition=fundamental","pubTime":"2026-10-31 11:40","pubTimestamp":1793418051,"startTime":"0","endTime":"0","summary":"The recent record crypto hack at Binance has reminded everyone how fragile trust can be when leaders are not visibly aligned with users. Founder led businesses often put their own reputation and wealth on the line, and this can create a powerful incentive to protect shareholder value. This article walks through three stocks run by their original builders, and explains why their commitment might matter to your portfolio now.\nThe three stocks highlighted here offer a compelling starting point...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/8043000-choice1-card/1789094663358","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/8043000-choice1-card/1789094663358"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/media/hkg-3888/kingsoft-shares/news/elite-founder-led-stocks-to-own-in-october-2026-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/media/hkg-3888/kingsoft-shares/news/elite-founder-led-stocks-to-own-in-october-2026-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VTHR","AGIX","IE00BVYPNP33.GBP","SG9999015986.USD","SG9999004311.SGD","ARTY","QTOC","SG9999015952.SGD","IE00BMCWC346.EUR","IE00BYV24P56.USD","SG9999004220.SGD","IE00BVYPNQ40.USD","AIPO","BK1191","00867","SG9999015978.USD","SG9999015945.SGD","CHAT","LU2488822045.USD","BK1593","IE00BGHQDM52.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674865101","title":"Humana is the 'Biggest Winner' From CMS' Medicare Advantage Star Ratings Impact on 2028 Reimbursements, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865101","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674865101?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:46","pubTimestamp":1791564368,"startTime":"0","endTime":"0","summary":"Humana  is the \"overwhelming\" winner from the Centers for Medicare & Medicaid Services' Medicare Advantage Star Ratings impact on 2028 reimbursements, Oppenheimer said in a Thursday research report.CMS released Star Ratings affecting 2028 reimbursement, with 4+ Star Rating membership exposure at 71% compared with 64% a year earlier, analysts wrote.The brokerage estimated that with 95% of Humana members in 4+ Star plans, the difference will account for over $3.6 billion in revenue for the company, resulting in around $20 in EPS if not passed through to bids, according to the note.Humana's membership-weighted average Star Rating grew from 53% to 95%, driven by a rebound in the national contract, according to Oppenheimer.The brokerage said it reiterated its outperform rating on the stock and increased its price target to $475 per share from $405.Price: 434.65, Change: +47.53, Percent Change: +12.28","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XHS","XLVX","IEHS","00867","LNGR","IHF","UNHU","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674418007","title":"Lantheus Holdings (LNTH) Gains CMS Reimbursement Win Following A Fair Value Debate","url":"https://stock-news.laohu8.com/highlight/detail?id=2674418007","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674418007?lang=en_us&edition=fundamental","pubTime":"2026-10-09 02:34","pubTimestamp":1791484440,"startTime":"0","endTime":"0","summary":"Lantheus Holdings (LNTH) just picked up a fresh reimbursement win, with CMS granting Transitional Pass Through payment status and a permanent HCPCS code for its PYLARIFY TruVu PET imaging agent.\nLantheus Holdings’ latest reimbursement win comes after a powerful run, with the share price up 48.9% year to date and a 1-year total shareholder return of 87.1%. This comes even as the 90-day share price return declined 5.5% and shorter-term momentum cooled.\nSpot similar reimbursement and product...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6022000-choice1-card/1788992506868","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6022000-choice1-card/1788992506868"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lnth/lantheus-holdings/news/lantheus-holdings-lnth-gains-cms-reimbursement-win-following","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lnth/lantheus-holdings/news/lantheus-holdings-lnth-gains-cms-reimbursement-win-following","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK1191","SG9999004220.SGD","IE00BVYPNP33.GBP","00867","SG9999004311.SGD","LU2488822045.USD","SG9999015986.USD","SG9999015945.SGD","BK1593","BK4198","SG9999015978.USD","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","SG9999015952.SGD","IE00BYV24P56.USD","IE00BVYPNQ40.USD","BK4585","LNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672750840","title":"Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672750840","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672750840?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:01","pubTimestamp":1790859660,"startTime":"0","endTime":"0","summary":"Application represents an important step in supporting reimbursement  Company remains on track for U.S. commercial launch of LYTENAVA before year-end 2026 ISELIN, N.J., Oct.  01, 2026 (GLOBE NEWSWIRE)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3372980/0/en/outlook-therapeutics-submits-hcpcs-level-ii-application-to-cms-for-permanent-j-code-for-lytenava-bevacizumab-vikg.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMHX","BK4573","AMDL","LU2417539215.USD","BAI","LENZ","WUGI","TRFK","00867","XNTK","LEGR","DAMD","AMDU","LU0672654240.SGD","AMDG","LU1267930730.SGD","AIS","PSI","TTEQ","TEK","ILDR","AMYY","LU2355687059.USD","USXF","LU2637428348.USD","AMDC","AMUU","CNAV","IETC","QQQA","SGXZ99366536.SGD","AMDD","SAMD0main","FAI","CHPS","AIQ","AMDS","FTXL","SOXY","CHAT","LU0274383776.USD","GAMR","AMDY","AMD","SMH","SOXX","AMDW","CMS","ARTY","WISE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672786539","title":"China Medical System Says Singapore Share Transfer Agent to Rename to Ascentium Corporate Services from Oct. 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2672786539","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672786539?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:04","pubTimestamp":1790784262,"startTime":"0","endTime":"0","summary":"China Medical System says Singapore share transfer agent to rename to Ascentium Corporate Services from Oct. 1China Medical System said its Singapore share transfer agent will operate under a new corp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL5Hq0TH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004311.SGD","IE00BYV24P56.USD","SG9999015986.USD","IE00BVYPNP33.GBP","00867","SG9999015945.SGD","SG9999015978.USD","IE00BGHQDM52.EUR","SG9999004220.SGD","BK1593","SG9999015952.SGD","IE00BMCWC346.EUR","BK1191","LU2488822045.USD","IE00BVYPNQ40.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148484592","title":"CMS Announces Renaming of Singapore Share Transfer Agent to Ascentium Corporate Services","url":"https://stock-news.laohu8.com/highlight/detail?id=1148484592","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148484592?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:43","pubTimestamp":1790761437,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited (CMS) reported that its Singapore share transfer agent will change its legal name from “In.Corp Corporate Services Pte. Ltd.” to “Ascentium Corporate Services...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128794768","title":"CMS Maintains Stable Share Structure in September 2026; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1128794768","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128794768?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:43","pubTimestamp":1790761406,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited (CMS) reported no changes to its share capital structure for the month ended 30 September 2026, according to the company’s monthly return filed with Hong Kong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669193711","title":"CMS Announces Preliminary Medicare Payment Rates for Laboratory Services in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669193711","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669193711?lang=en_us&edition=fundamental","pubTime":"2026-09-22 05:19","pubTimestamp":1790025544,"startTime":"0","endTime":"0","summary":"The preliminary 2027 payment rates for most laboratory services under the Medicare Clinical Laboratory Fee Schedule are based on data collected from laboratories, and the final rates will not be released until later this year, according to a statement.The preliminary 2027 payment rates for most laboratory services under the Medicare Clinical Laboratory Fee Schedule are based on data collected from laboratories and will not be released until later this year, according to a statement.By law, Medicare payments for clinical diagnostic laboratory tests cannot be lowered by more than 15% annually through 2029. CMS will gradually reduce rates through 2029, the statement added.The final payment rates will go into effect starting Jan. 1, 2027.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BYV24P56.USD","LU2488822045.USD","IE00BVYPNQ40.USD","IE00BGHQDM52.EUR","SG9999015986.USD","SG9999015952.SGD","BK1191","SG9999004311.SGD","LNGR","IE00BMCWC346.EUR","SG9999015978.USD","BK1593","SG9999015945.SGD","00867","IE00BVYPNP33.GBP","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153189370","title":"Lazard Asset Management Raises Stake in CMS with 1.265 Million Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1153189370","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153189370?lang=en_us&edition=fundamental","pubTime":"2026-09-16 08:10","pubTimestamp":1789517419,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange disclosures reveal that on September 2, Lazard Asset Management LLC increased its position in CMS (00867) by purchasing 1.265 million shares at an average price of HKD 10.947...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","SG9999015986.USD","IE00BVYPNQ40.USD","SG9999004311.SGD","BK1191","SG9999015952.SGD","IE00BMCWC346.EUR","SG9999015945.SGD","00867","IE00BYV24P56.USD","BK1593","SG9999015978.USD","SG9999004220.SGD","IE00BGHQDM52.EUR","EWH","IE00BVYPNP33.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668509","title":"China Medical System Gets China Nod for Lupus Erythematosus Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668509","media":"MT Newswires","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668509?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:12","pubTimestamp":1789384366,"startTime":"0","endTime":"0","summary":"China Medical System Holdings  obtained clinical trial approval for its CMS-D001 tablets from China's National Medical Products Administration.The trial will evaluate the safety and efficacy of CMS-D001 for the treatment of systemic lupus erythematosus, according to a Monday bourse filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNP33.GBP","SG9999004220.SGD","8A8.SI","IE00BGHQDM52.EUR","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999004311.SGD","IE00BYV24P56.USD","00867","SG9999015952.SGD","SG9999015978.USD","BK1593","BK1191","BK6079","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170311528","title":"CMS Secures Clinical Trial Green Light for Innovative Lupus Treatment Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1170311528","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170311528?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:26","pubTimestamp":1789381603,"startTime":"0","endTime":"0","summary":"CMS has announced that its innovative drug candidate, CMS-D001 tablets, received a clinical trial approval notice from China's National Medical Products Administration (NMPA) on September 11, 2026,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","IE00BYV24P56.USD","06978","IE00BMCWC346.EUR","IE00BVYPNP33.GBP","SG9999004311.SGD","BK1574","LU2488822045.USD","BK1161","159992","SG9999015978.USD","LNGR","BK1593","MDTX","IE00BVYPNQ40.USD","BMED","IBBQ","IE00BGHQDM52.EUR","MEDX","IBBJ","SG9999015986.USD","SG9999004220.SGD","PSYK","SG9999015952.SGD","SG9999015945.SGD","00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667571416","title":"China Medical System Holdings - CMS-D001 Granted Drug Clinical Trial Approval Notice by Nmpa on Sept 11, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667571416","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667571416?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:21","pubTimestamp":1789381294,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN45501W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BMCWC346.EUR","BK1593","SG9999015952.SGD","00867","BK1191","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","SG9999015986.USD","SG9999015978.USD","SG9999004220.SGD","LU2488822045.USD","SG9999004311.SGD","SG9999015945.SGD","IE00BYV24P56.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666581721","title":"CMS: Initial Prescriptions for Silevimig Injection, the World’s First Bispecific Antibody Against Rabies, Issued in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2666581721","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666581721?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:41","pubTimestamp":1788946860,"startTime":"0","endTime":"0","summary":"SHENZHEN, CHINA, Sept.  09, 2026 (GLOBE NEWSWIRE) -- On 9 September, China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS” or the “Group”) is pleased to announce that the initial prescriptions ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358397/0/en/cms-initial-prescriptions-for-silevimig-injection-the-world-s-first-bispecific-antibody-against-rabies-issued-in-china.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","SG9999015945.SGD","SG9999015978.USD","IE00BVYPNQ40.USD","SG9999004311.SGD","SG9999004220.SGD","IE00BMCWC346.EUR","BK1191","00867","IE00BYV24P56.USD","SG9999015952.SGD","IE00BVYPNP33.GBP","SG9999015986.USD","IE00BGHQDM52.EUR","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664087717","title":"CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664087717","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664087717?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:08","pubTimestamp":1788437280,"startTime":"0","endTime":"0","summary":"SHENZHEN, CHINA, Sept.  03, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355884/0/en/cms-867-hk-8a8-sg-innovative-drug-lumirix-approved-in-china-for-additional-indication-of-atopic-dermatitis-ad.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1223083913.SGD","SG9999015945.SGD","LU2488822045.USD","SGDM","GDXJ","SG9999015986.USD","BK1191","TCS","IE00BGHQDM52.EUR","IE00BVYPNP33.GBP","SIL","IE00BYV24P56.USD","AD","SG9999015978.USD","00867","XME","BK4132","LU1223082519.USD","IE00BVYPNQ40.USD","SG9999004220.SGD","SG9999015952.SGD","CDE","BK4017","LU1223082196.USD","BK4200","IE00BMCWC346.EUR","BK1593"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cms.net.cn","stockEarnings":[{"period":"1week","weight":0.0733},{"period":"1month","weight":0},{"period":"3month","weight":-0.0988},{"period":"6month","weight":-0.0841},{"period":"1year","weight":-0.2138},{"period":"ytd","weight":-0.1596}],"compareEarnings":[{"period":"1week","weight":0.0438},{"period":"1month","weight":0.0143},{"period":"3month","weight":-0.0347},{"period":"6month","weight":-0.0694},{"period":"1year","weight":-0.0785},{"period":"ytd","weight":-0.0419}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Medical System Holdings Limited is an investment holding company mainly engaged in the pharmaceutical products business. The Company operates its business through two segments. The Integrated Pharmaceuticals Portfolio segment is engaged in the research and development, manufacturing and sales of pharmaceutical products. The Skin Health Business segment is engaged in the promotion and sales of skin disease related pharmaceutical products.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.010937},{"month":2,"riseRate":0.6,"avgChangeRate":0.034686},{"month":3,"riseRate":0.4375,"avgChangeRate":-0.007408},{"month":4,"riseRate":0.5,"avgChangeRate":0.025614},{"month":5,"riseRate":0.4375,"avgChangeRate":-0.000084},{"month":6,"riseRate":0.625,"avgChangeRate":0.003749},{"month":7,"riseRate":0.5625,"avgChangeRate":0.001831},{"month":8,"riseRate":0.375,"avgChangeRate":0.017711},{"month":9,"riseRate":0.4375,"avgChangeRate":0.002556},{"month":10,"riseRate":0.470588,"avgChangeRate":0.002951},{"month":11,"riseRate":0.588235,"avgChangeRate":0.055455},{"month":12,"riseRate":0.5625,"avgChangeRate":0.034382}],"exchange":"SEHK","name":"CMS","nameEN":"CMS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CMS(00867),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CMS(00867) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CMS,00867,CMS股票,CMS股票老虎,CMS股票老虎国际,CMS行情,CMS股票行情,CMS股价,CMS股市,CMS股票价格,CMS股票交易,CMS股票购买,CMS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CMS(00867),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CMS(00867) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}